Introduced by A*Star’s ICES, the new program offers a platform for pharma and specialty chemicals industry to deal with challenges, including costs, regulatory compliance and responsiveness in production and processes to bring drugs from trials to markets.
Enabling companies to access advanced processing technologies, the program will help companies to boost productivity and enhance manpower development to maintain their competitive edge.
ICES executive director Dr. Keith Carpenter said that companies can mutually benefit from joint research, by recognizing common research goals.
"This will enable companies to address industry-wide challenges and further reinforce the competitiveness of Singapore’s chemicals industry," Carpenter added.
Besides addressing concerns such as cost, quality, environmental impact and process robustness, the program also offers a platform for members to discuss, develop and grow the industry processing technology knowledge base by technology transfer and manpower development.
Leveraging established resources and capabilities at ICES, the program will carry out researches undertaken in industrially relevant areas like process analytics (PAT), Quality by Design (Qbd) as well as continuous manufacturing systems.
Providing an edge to meet the emerging needs of Asian customers and end-consumers, the consortium provides sufficient opportunities for companies to expand their presence in Singapore.